IMPRINT will issue regular calls in order to support research and to foster public engagement within the network and beyond.

Call closed: Progression Grants

Submission deadline: 15 March, 16:00 CET

This call is directed at IMPRINT members from all geographical regions who have existing data/samples that would benefit from further collaborative research in order to deepen mechanistic insights into the immune responses of the mother/infant dyad in the context of vaccination and help understand transplacental antibody in unprecedented depth.

The research proposed ought to focus on the Biological Challenges 1-3 amongst the IMPRINT stated research objectives, for example by applying novel technologies such as glycosylation profiling, neutralisation assays, proteomics and other “omic” technologies to already stored samples from clinical trials conducted by members of the IMPRINT network or existing datasets that could be analysed using novel data analysis approaches/combined datasets to increase power or validation.

Applications from researchers at all levels (PI, postdoc, early career) based in LMIC with partners in either other LMIC or HIC are particularly welcome.

  • Funds of up to £100,000 per project will be available to IMPRINT members and their collaborators for progression projects of 12-15 months addressing key challenges.

  • Applications will be assessed by the scientific committee and external reviewers, using a transparent application process and scoring system, which will evaluate scientific excellence and strategic fit.

  • Proposals should involve at least two collaborating IMPRINT research groups and are open to external partners.

To apply, please download the application form below. For further information about the call and application details please see the application guidance below.

More Details

Please refer to the respective guidance documents. For any additional queries, don’t hesitate to contact the network manager at

MRC data sharing

For information on good practice principles for sharing participant data from publicly funded clinical and trials and on how to manage your research data, please refer to:

UKRI/MRC open access policy

For MRC open access policy, guidance and FAQ, please refer to: